Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9060563rdf:typepubmed:Citationlld:pubmed
pubmed-article:9060563lifeskim:mentionsumls-concept:C0008059lld:lifeskim
pubmed-article:9060563lifeskim:mentionsumls-concept:C1516476lld:lifeskim
pubmed-article:9060563lifeskim:mentionsumls-concept:C0684224lld:lifeskim
pubmed-article:9060563lifeskim:mentionsumls-concept:C0002210lld:lifeskim
pubmed-article:9060563lifeskim:mentionsumls-concept:C0206624lld:lifeskim
pubmed-article:9060563lifeskim:mentionsumls-concept:C1522484lld:lifeskim
pubmed-article:9060563lifeskim:mentionsumls-concept:C2698872lld:lifeskim
pubmed-article:9060563lifeskim:mentionsumls-concept:C1274040lld:lifeskim
pubmed-article:9060563lifeskim:mentionsumls-concept:C0441889lld:lifeskim
pubmed-article:9060563lifeskim:mentionsumls-concept:C0036525lld:lifeskim
pubmed-article:9060563lifeskim:mentionsumls-concept:C0449243lld:lifeskim
pubmed-article:9060563lifeskim:mentionsumls-concept:C1522326lld:lifeskim
pubmed-article:9060563lifeskim:mentionsumls-concept:C1704240lld:lifeskim
pubmed-article:9060563lifeskim:mentionsumls-concept:C1519810lld:lifeskim
pubmed-article:9060563pubmed:issue3lld:pubmed
pubmed-article:9060563pubmed:dateCreated1997-3-31lld:pubmed
pubmed-article:9060563pubmed:abstractTextWe analyzed data on 31 children with primary unresectable or metastatic hepatoblastoma (HB) to investigate possible prognostic correlations between the serum level of alpha-fetoprotein (AFP), its changes during treatment, and outcome.lld:pubmed
pubmed-article:9060563pubmed:languageenglld:pubmed
pubmed-article:9060563pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9060563pubmed:citationSubsetIMlld:pubmed
pubmed-article:9060563pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9060563pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9060563pubmed:statusMEDLINElld:pubmed
pubmed-article:9060563pubmed:monthMarlld:pubmed
pubmed-article:9060563pubmed:issn0732-183Xlld:pubmed
pubmed-article:9060563pubmed:authorpubmed-author:HammondG DGDlld:pubmed
pubmed-article:9060563pubmed:authorpubmed-author:OrtegaJ AJAlld:pubmed
pubmed-article:9060563pubmed:authorpubmed-author:FeusnerJ HJHlld:pubmed
pubmed-article:9060563pubmed:authorpubmed-author:KingD RDRlld:pubmed
pubmed-article:9060563pubmed:authorpubmed-author:BuckleyJ DJDlld:pubmed
pubmed-article:9060563pubmed:authorpubmed-author:QuinnJ JJJlld:pubmed
pubmed-article:9060563pubmed:authorpubmed-author:Van...lld:pubmed
pubmed-article:9060563pubmed:authorpubmed-author:KrailoM DMDlld:pubmed
pubmed-article:9060563pubmed:issnTypePrintlld:pubmed
pubmed-article:9060563pubmed:volume15lld:pubmed
pubmed-article:9060563pubmed:ownerNLMlld:pubmed
pubmed-article:9060563pubmed:authorsCompleteYlld:pubmed
pubmed-article:9060563pubmed:pagination1190-7lld:pubmed
pubmed-article:9060563pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:9060563pubmed:meshHeadingpubmed-meshheading:9060563-...lld:pubmed
pubmed-article:9060563pubmed:meshHeadingpubmed-meshheading:9060563-...lld:pubmed
pubmed-article:9060563pubmed:meshHeadingpubmed-meshheading:9060563-...lld:pubmed
pubmed-article:9060563pubmed:meshHeadingpubmed-meshheading:9060563-...lld:pubmed
pubmed-article:9060563pubmed:meshHeadingpubmed-meshheading:9060563-...lld:pubmed
pubmed-article:9060563pubmed:meshHeadingpubmed-meshheading:9060563-...lld:pubmed
pubmed-article:9060563pubmed:meshHeadingpubmed-meshheading:9060563-...lld:pubmed
pubmed-article:9060563pubmed:meshHeadingpubmed-meshheading:9060563-...lld:pubmed
pubmed-article:9060563pubmed:meshHeadingpubmed-meshheading:9060563-...lld:pubmed
pubmed-article:9060563pubmed:meshHeadingpubmed-meshheading:9060563-...lld:pubmed
pubmed-article:9060563pubmed:meshHeadingpubmed-meshheading:9060563-...lld:pubmed
pubmed-article:9060563pubmed:meshHeadingpubmed-meshheading:9060563-...lld:pubmed
pubmed-article:9060563pubmed:meshHeadingpubmed-meshheading:9060563-...lld:pubmed
pubmed-article:9060563pubmed:meshHeadingpubmed-meshheading:9060563-...lld:pubmed
pubmed-article:9060563pubmed:meshHeadingpubmed-meshheading:9060563-...lld:pubmed
pubmed-article:9060563pubmed:meshHeadingpubmed-meshheading:9060563-...lld:pubmed
pubmed-article:9060563pubmed:meshHeadingpubmed-meshheading:9060563-...lld:pubmed
pubmed-article:9060563pubmed:year1997lld:pubmed
pubmed-article:9060563pubmed:articleTitleTiming and magnitude of decline in alpha-fetoprotein levels in treated children with unresectable or metastatic hepatoblastoma are predictors of outcome: a report from the Children's Cancer Group.lld:pubmed
pubmed-article:9060563pubmed:affiliationDepartment of Pediatrics, University of Southern California School of Medicine, Los Angeles, USA.lld:pubmed
pubmed-article:9060563pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:9060563pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:9060563pubmed:publicationTypeMulticenter Studylld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9060563lld:pubmed